BFRIW 8-K 2026-09-14

Biofrontera Inc. (BFRIW) 8-K dated 2026-09-14 — accession 0001493152-26-042508. This URL is the filing, not the BFRIW hub.

Biofrontera Inc. (BFRIW) is a drug manufacturers - specialty & generic company listed on US.

Biofrontera Inc. filed a 8-K on 2026-09-14. Accession 0001493152-26-042508.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BFRIW revenue for 2025-12-31 was $41.7M. Net income was -$10.5M. Revenue was up 11.7% from 2024-12-31 to 2025-12-31. BFRIW currently screens at market cap $73.9K.

Not investment advice. The BFRIW SEC hub lists recent forms. The stock page is the research view.